titlesubmit dateissue date
Now showing items 1-6 of 6
Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO).
Eligibility for and outcome of treatment of latent tuberculosis infection in a cohort of HIV-infected people in Spain
Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013.
Neurocognitive impairment in patients treated with protease inhibitor monotherapy or triple drug antiretroviral therapy
Novel association of five HLA alleles with HIV-1 progression in Spanish long-term non progressor patients
Self-rated health among people living with HIV in Spain in 2019: a cross-sectional study.